Similarly, the increases in H274Y raised concerns that cases could become more severe because of initial treatment with Tamiflu or subsequent treatment with Peramivir would have limited effect. Thus, the resistance could limit treatment …
With the recent H1N1 flu pandemic, the use of many anti-viral drugs, especially Tamiflu (Oseltamivir), has increased dramatically. Just like the resistance to antibiotics, resistance to anti-viral treatments occurs, but at a much faster rate.
More:
Signpost – Anti-virals are not so amazing (The Weber State University Signpost)
Seven passengers on a train developed H1N1 infections that had H274Y. However, like most patients worldwide, the resistance was not discovered until long after treatment and discharge. The infections were in July, but the first lab …
Read more here:
Tamiflu Resistance Spike in US Raises Transparency Concerns « The …
Today the NEJM has published a letter from investigators in Vietnam that outlines the community transmission of a `fit’ oseltamivir (Tamiflu) resistant strain of the pandemic H1N1 virus. While several dozen cases of Tamiflu resistant novel H1N1 have been reported, … The potential loss of treatment options is something to seriously onsider when deciding about whether to take the H1N1 vaccine. Posted by FLA_MEDIC at 8:45 PM. Labels: Cluster, NEJM, Resistance, Tamiflu …
Continue reading here:
NEJM: Community Cluster Of Tamiflu Resistant H1N1
NexBio, Inc. announced the presentation of new data at the 2009 annual American College of Allergy, Asthma, and Immunology in Miami, Florida. The presentation was entitled “DAS181 (Fludase®), a Sialidase, Decreases Airway Resistance and Has Potent Anti-inflammatory Effects in Animal Models of Asthma”.
The rest is here:
NexBio(R) Presents Data Showing Anti-Asthma Activity Of DAS181 (Fludase(R)) At ACAAI 2009 (Medical News Today)